fgf-5
Vaccineexperimental
Fibroblast growth factor 5 is a protein that in humans is encoded by the FGF5 gene. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00089778)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Acidic fibroblast growth factorSupplementation
FGF1 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFGF5 ↗
Also known as
- fgf-5
- fibroblast growth factor 5
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00089778 | Phase 2 | Aug 1, 2004 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2004 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1